Study S000599

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity. 56-week, Double-blind, Randomised, Parallel-group, Placebo-controlled Multi-national Trial Followed by a 26-week Period Off Study-drug

Included trial: extracted data ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT02918279
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: COMPLETED
Enrollment: 251
Start: 2016-09-29
Primary completion: 2019-02-14
Lead sponsor: Novo Nordisk A/S
Conditions: Metabolism and Nutrition Disorder; Obesity
Interventions: DRUG:Liraglutide; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: EUDRACT_NUMBER:2014-004353-14; OTHER:U1111-1162-7101; NIH:2014

Registered primary outcomes

Change in BMI SDS (Week 0, Week 56) [Week 0, week 56]

Linked records (4)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0021147	Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial. Bensignor MO, Pediatric obesity	2023	Randomized trial	PMID 37264767 DOI	cites ClinicalTrials.gov:NCT02918279; registry reference DERIVED:37264767
R0033796	Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial Endocrine Society 2020, Underline Science Inc.	2022	Randomized trial	DOI	cites ClinicalTrials.gov:NCT02918279
R0023922	A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. Kelly AS, The New England journal of medicine	2020	Randomized trial	PMID 32233338 DOI	cites ClinicalTrials.gov:NCT02918279; registry reference RESULT:32233338
R0024039	OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial Kelly A, Journal of the Endocrine Society	2020	Randomized trial	DOI	cites ClinicalTrials.gov:NCT02918279